![Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research - ScienceDirect Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1556086415314088-gr1.jpg)
Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research - ScienceDirect
![PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network](https://i1.rgstatic.net/publication/336972259_Treatment_beyond_four_cycles_of_first_line_Platinum_and_Etoposide_chemotherapy_in_real-life_patients_with_stage_IV_Small_Cell_Lung_Cancer_a_retrospective_study_of_the_Merseyside_and_Cheshire_Cancer_ne/links/5dbcd62b299bf1a47b0a4680/largepreview.png)
PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network
![Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-28840-5/MediaObjects/41467_2022_28840_Fig1_HTML.png)
Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications
![The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study](https://www.jcancer.org/v12/p5644/jcav12p5644g003.jpg)
The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study
![Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study | Anticancer Research Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/6/3735/F4.large.jpg)
Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study | Anticancer Research
![P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether](https://thorax.bmj.com/content/thoraxjnl/67/Suppl_2/A151.1/F1.large.jpg)
P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether
![Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis - ScienceDirect Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0041008X2200182X-ga1.jpg)
Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis - ScienceDirect
![Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500215001725-gr2.jpg)
Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect
![Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian | Cancer Cell International | Full Text Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-022-02588-w/MediaObjects/12935_2022_2588_Fig3_HTML.png)
Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian | Cancer Cell International | Full Text
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr2.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr1.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network](https://www.researchgate.net/publication/336972259/figure/fig3/AS:962802894262279@1606561506425/Kaplan-Meyer-curve-of-time-from-last-chemotherapy-cycle-to-date-of-progression-or-death_Q320.jpg)